We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Prolonged ICU Stay Depopulates Healthy Gut Microbiota

By HospiMedica International staff writers
Posted on 07 Oct 2014
A new study shows that a long stay in the intensive care unit (ICU) drastically reduces the number of microbe species found in patients' intestines.

Researchers at the University of Chicago (IL, USA), Argonne National Laboratory (Argonne, IL, USA), and other institutions analyzed fecal samples of selected patients during a prolonged stay in an ICU to find the 16S rRNA amplicon composition of their gut bacteria. More...
They found that the 30% of the patients had only 1–4 types of microbes present, compared to about 40 found in healthy volunteers. Four of the patients presented a lowly two-member community comprised of an infectious Candida yeast strain and a pathogenic bacterial strain, such as E. faecium or S. aureus.

To examine the virulence potential of the two-member communities, the researchers examined how the Caenorhabditis elegans worm behaved during nutrient deprivation and exposure to opioids, mimicing local conditions in the gut during critical illness. Under conditions of nutrient deprivation, the bacterial members attenuated the virulence of fungal members, but maintained a commensal lifestyle. However, exposure to opioids led to a breakdown in this commensalism and the creation of a potentially deadly pathogenic state. The study was published on September 23, 2014, in mBio.

“They've got a lot of bad guys in there, but the presence of bad guys alone doesn't tell you who's going to live or die,” said lead author gastrointestinal surgeon John Alverdy, MD, of the University of Chicago. “It's not only which microbes are there, but how they behave when provoked by the harsh and hostile conditions of critical illness.”

The researchers suggest that doctors try to find ways to minimize the excessive use of antibiotics and stabilize the microbes remaining in ICU patients' guts. They suggest this might be achieved by application of phosphate-polyethylene glycol (Pi-PEG), an antivirulence agent that creates local phosphate abundance, thus preventing opioid-induced virulence among pathogenic communities and rescuing the commensal lifestyle.

Related Links:

University of Chicago
Argonne National Laboratory



Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Digital Color Doppler Ultrasound System
MS22Plus
Emergency Ventilator
Shangrila935
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.